Amoveo Unscented

Manufacturer: Protair-X Health Solutions Inc.
Effective date: 2017-02-24
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:48:59

Label at a glance#

ProductAmoveo Unscented

Active ingredientALCOHOL

Label structure8 sections

Indications and uses

For handwashing to decrease bacteria on the skin Recommended for repeated use

Dosage and administration

Wet hands thoroughly with product and allow to dry without wiping

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Alcohol 70%

Purpose

OTC - PURPOSE SECTION

Antiseptic

Uses

INDICATIONS & USAGE SECTION

For handwashing to decrease bacteria on the skin
Recommended for repeated use

Warnings

WARNINGS SECTION

For external use only.
Flammable, keep away from fire or flame.

Do not use

OTC - DO NOT USE SECTION

in the eyes

Stop use and ask a doctor if:

OTC - STOP USE SECTION

irritation and redness develop
condition persists for more than 72 hours

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Wet hands thoroughly with product and allow to dry without wiping

Other Information

SPL UNCLASSIFIED SECTION

avoid temperatures over 110°F
may discolor certain fabrics
harmful to wood finishes and plastics

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Carbomer, Glycerin, Triethanolamine, Water

Questions?

OTC - QUESTIONS SECTION

Call 1 - 877 - 874 - 0606 Weekdays, 9AM – 5PM EST

Package Labeling:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label3

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
581662	ethanol 70 % Topical Gel	PSN	1
581662	ethanol 0.7 ML/ML Topical Gel	SCD	1
581662	ethanol 70 % Topical Gel	SY	1
581662	ethyl alcohol 70 % Topical Gel	SY	1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
49955-702-01	2023-01-30	C162847	48780-1	f386c64a-19ea-0266-e053-dadaa90a7c1a	Amoveo Unscented
49955-702-50	2023-01-30	C162847	48780-1	f386c64a-19ea-0266-e053-dadaa90a7c1a	Amoveo Unscented

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
49955-702-01	Amoveo Unscented	1000 mL in 1 BOTTLE	GEL	1000		1
49955-702-50	Amoveo Unscented	500 mL in 1 BOTTLE	GEL	500		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49955-702	AMOVEO UNSCENTED (ALCOHOL) GEL [PROTAIR-X HEALTH SOLUTIONS INC.]	1	Legacy NDC, 2 package rows	20170301_494b48be-e248-332f-e054-00144ff88e88.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

Amoveo Unscented
ALCOHOL
CARBOXYPOLYMETHYLENE
GLYCERIN
TROLAMINE
WATER

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
49955-702	49955-702-50, 49955-702-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CARBOXYPOLYMETHYLENE	0A5MM307FC	IACT
GLYCERIN	PDC6A3C0OX	IACT
TROLAMINE	9O3K93S3TK	IACT
WATER	059QF0KO0R	IACT
ALCOHOL	3K9958V90M	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
494b48be-e249-332f-e054-00144ff88e88			494b48be-e248-332f-e054-00144ff88e88	2017-02-24	Warnings	Exact identifier spl id: 494b48be-e249-332f-e054-00144ff88e88 spl set id: 494b48be-e248-332f-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.